Tag: pharmaceutical AI
Chai Discovery raises $400 million Series C for AI drug design
The startup behind AI molecule models used by Lilly, Novartis and Pfizer hits a $3.8 billion valuation.
Bigger AI models don’t always win in drug metabolism prediction
The OpenADMET challenge found that smaller, specialized models matched or beat large foundation models at predicting how the body processes…